Application of pterostilbene in preparation of host intestinal flora regulator for resisting salmonella infection

By using Salmonella as a host microbiota regulator, Salmonella significantly inhibited and upregulated the beneficial bacteria in intestinal bacteria in mice, the problem of drug resistance in Salmonella infection was solved and a new treatment strategy for reducing antibiotic dependence was provided.

CN118903073APending Publication Date: 2024-11-08JILIN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411103617.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The problem of drug resistance of existing antibiotics to treat Salmonella infection is becoming increasingly serious, and new anti-infection strategies and drugs are urgently needed to prevent and treat Salmonella infection.

Method used

The abundance of beneficial bacterial flora was used as the host bacterial flora regulator, and it was screened through animal tests and confirmed that it had a significant inhibitory effect on Salmonella, and upregulated the abundance of beneficial bacterial flora in the intestine of mice to reduce Salmonella infection.

Benefits of technology

The sarcoidae significantly reduced the colony colonization number of Salmonella in the mouse target organs, and the minimum inhibitory concentration of Salmonella is higher than 256μg/mL, which does not affect Salmonella growth, and provides a new antibiotic that is not dependent on the target host. Effect strategy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903073A_ABST
    Figure CN118903073A_ABST
Patent Text Reader

Abstract

The invention relates to a medical application of pterostilbene in preparation of a host intestinal flora regulator. The pterostilbene is verified to have a good regulation effect on host salmonella infection resistance through MIC, a salmonella growth curve, 16S rRNA analysis and cecum and colon colony colonization tests in a mouse salmonella infection model. Due to abuse of traditional antibiotics and continuous enhancement of bacterial drug resistance, pterostilbene has the characteristics of low cost, no drug resistance, no drug residue and high cure rate. Therefore, when pterostilbene is used for preventing and treating salmonella infection, the drug selectivity can be improved, and the pterostilbene has a wide application prospect and is of great significance to the development of new drugs.
Need to check novelty before this filing date? Find Prior Art